The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A comprehensive analysis of clinical and tumor characteristics with BRAF and KRAS mutations status in adjuvant colon cancer trial N0147.
Robert R. McWilliams
No relevant relationships to disclose
Michelle R. Mahoney
No relevant relationships to disclose
Daniel J. Sargent
No relevant relationships to disclose
Garth D. Nelson
No relevant relationships to disclose
Frank Sinicrope
No relevant relationships to disclose
Paul J Limburg
No relevant relationships to disclose
Stephen N. Thibodeau
No relevant relationships to disclose
Axel Grothey
No relevant relationships to disclose
Joleen Marie Hubbard
No relevant relationships to disclose
Steven R. Alberts
No relevant relationships to disclose